All In Biotech

Free tool

FAERS Monitor: Austedo Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216354 or its brand name (Austedo Xr, Deutetrabenazine). Reports on generic versions are filed under their own applications.

Reports

2,016

Serious

1,213

60% of reports

Hospitalization

322

Death reported

159

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective320
  • depression183
  • product use issue176
  • dyskinesia156
  • somnolence146
  • fatigue136
  • death131
  • product use in unapproved indication131
  • suicidal ideation119
  • tremor118
  • fall115
  • tardive dyskinesia113
  • insomnia104
  • dizziness100
  • off label use90

Reports by year received

View as table
YearReports
20172
20184
20198
20204
20214
202215
202359
2024485
2025734
2026701

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,143 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
tardive dyskinesiaSignal11342.035.14,465
dyskinesiaSignal15640.234.65,912
suicidal ideationSignal11913.611.41,378
product use issueSignal1769.88.51,389
depressionSignal1838.47.31,197
somnolenceSignal1467.66.5833
tremorSignal1187.46.2654
product use in unapproved indicationSignal1315.54.7485
insomniaSignal1044.13.4241
fallSignal1153.63.0217
drug ineffectiveSignal3202.52.3315
dizzinessSignal1002.11.757
fatigue1361.81.552
death1311.61.329
off label use901.10.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.